News Hexima Limited

Equities

Delayed Australian S.E. Other stock markets 08:50:54 2024-06-02 pm EDT			5-day change	1st Jan Change
0.01 ^AUD	0.00%		0.00%	-44.44%

Mar. 22	Hexima Secures R&D Tax Rebate for Fiscal Year 2023	MT
Mar. 19	Hexima Changes Address	MT

Hexima Secures R&D Tax Rebate for Fiscal Year 2023	Mar. 21	MT
Hexima Changes Address	Mar. 19	MT
Hexima Limited Announces Change of Address	Mar. 19	CI
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2023	Feb. 28	CI
Hexima Limited Announces the Resignation of Dr. Nicole Van Der Weerden as Director	Nov. 29	CI
Hexima Limited Appoints Phillip Hains as A Non-Executive Director	23-09-18	CI
Hexima Limited Appoints Geoffrey Kempler as Managing Director	23-09-05	CI
Hexima Limited Announces Executive Changes	23-09-05	CI
Hexima Limited Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-31	CI
Hexima Limited Announces Resignation of Mr. Steven Skala as an Alternate Director	23-05-11	CI
Hexima Limited Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-27	CI
Hexima Limited Declares Voting Results	23-01-30	CI
Arovella Therapeutics Appoints COO	23-01-03	MT
Hexima Acting CEO to Step Down	22-12-22	MT
Nicole Van Der Weerden to Step Down as CEO of Hexima Limited	22-12-22	CI
Hexima Receives AU$6 Million Tax Incentive Refund from Australian Taxation Office	22-12-14	MT
Hexima Limited Receives Requisition Notice from Merchant Biotech Fund	22-12-13	CI
Hexima Limited Announces Board Changes	22-12-04	CI
10,150,000 Options of Hexima Limited are subject to a Lock-Up Agreement Ending on 1-DEC-2022.	22-11-30	CI
6,925,878 Ordinary Shares of Hexima Limited are subject to a Lock-Up Agreement Ending on 1-DEC-2022.	22-11-30	CI

No results for this search